CA2197785A1 - Oligonucleotide conjugates, compositions and methods for splitting ribonucleic acids - Google Patents

Oligonucleotide conjugates, compositions and methods for splitting ribonucleic acids

Info

Publication number
CA2197785A1
CA2197785A1 CA002197785A CA2197785A CA2197785A1 CA 2197785 A1 CA2197785 A1 CA 2197785A1 CA 002197785 A CA002197785 A CA 002197785A CA 2197785 A CA2197785 A CA 2197785A CA 2197785 A1 CA2197785 A1 CA 2197785A1
Authority
CA
Canada
Prior art keywords
oligonucleotide
oligonucleotide according
building blocks
group
target rna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002197785A
Other languages
English (en)
French (fr)
Inventor
Dieter Husken
Heinz Moser
Robert Haner
Jonathan Hall
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of CA2197785A1 publication Critical patent/CA2197785A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6816—Hybridisation assays characterised by the detection means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0042—Photocleavage of drugs in vivo, e.g. cleavage of photolabile linkers in vivo by UV radiation for releasing the pharmacologically-active agent from the administered agent; photothrombosis or photoocclusion
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
CA002197785A 1994-09-02 1995-08-30 Oligonucleotide conjugates, compositions and methods for splitting ribonucleic acids Abandoned CA2197785A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH269494 1994-09-02
CH2694/94-5 1994-09-02

Publications (1)

Publication Number Publication Date
CA2197785A1 true CA2197785A1 (en) 1996-03-14

Family

ID=4239485

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002197785A Abandoned CA2197785A1 (en) 1994-09-02 1995-08-30 Oligonucleotide conjugates, compositions and methods for splitting ribonucleic acids

Country Status (8)

Country Link
EP (1) EP0778845A1 (ja)
JP (1) JPH10505353A (ja)
AU (1) AU3519095A (ja)
CA (1) CA2197785A1 (ja)
FI (1) FI970696A0 (ja)
HU (1) HUT77034A (ja)
NO (1) NO970885L (ja)
WO (1) WO1996007667A1 (ja)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5798491A (en) * 1993-06-09 1998-08-25 Board Of Regents, The University Of Texas System Multi-mechanistic chemical cleavage using certain metal complexes
US5714328A (en) * 1995-06-07 1998-02-03 Board Of Regents, The University Of Texas System RNA photocleavage using texaphyrins
US6022959A (en) * 1996-08-20 2000-02-08 Pharmacyclics, Inc. Nucleic acids internally-derivatized with a texaphyrin metal complex and uses thereof
EP0920439B1 (en) * 1996-08-20 2003-04-02 Pharmacyclics, Inc. Nucleic acids internally-derivatized with a texaphyrin metal complex and uses thereof
US6255476B1 (en) * 1999-02-22 2001-07-03 Pe Corporation (Ny) Methods and compositions for synthesis of labelled oligonucleotides and analogs on solid-supports
KR101040700B1 (ko) * 2006-11-16 2011-06-10 주식회사 엘지화학 테레프탈알데히드의 정제방법
WO2008124614A1 (en) 2007-04-06 2008-10-16 Neurocrine Biosciences, Inc. Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
CL2008000985A1 (es) 2007-04-06 2008-10-10 Neurocrine Biosciences Inc Compuesto derivado de heterociclos de nitrogeno, agonistas del receptor gnrh; composicion farmaceutica que comprende a dicho compuesto; y uso para tratar una afeccion relacionada con las hormonas sexuales, endometriosis, dismenorrea, enfermedad de ov

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5559207A (en) * 1989-03-06 1996-09-24 Board Of Regents, University Of Texas Texaphyrin metal complex mediated ester hydrolysis

Also Published As

Publication number Publication date
HUT77034A (hu) 1998-03-02
FI970696A (fi) 1997-02-19
EP0778845A1 (de) 1997-06-18
NO970885D0 (no) 1997-02-27
NO970885L (no) 1997-04-25
JPH10505353A (ja) 1998-05-26
WO1996007667A1 (de) 1996-03-14
AU3519095A (en) 1996-03-27
FI970696A0 (fi) 1997-02-19

Similar Documents

Publication Publication Date Title
Tung et al. Polyamine-linked oligonucleotides for DNA triple helix formation
AU763518B2 (en) Ligand-conjugated oligomeric compounds
JP3172174B2 (ja) アキラル内部サブユニット結合を有する非帯電モルホリノに基づくポリメラーゼ
CA2160016C (en) Method of forming oligonucleotides
JP2004500330A (ja) グアニジニウム官能化オリゴマーとその製造法
WO1995023162A1 (en) Modified oligonucleotide duplexes having anticancer activity
WO2008017507A2 (en) Nanoparticle nucleic acid bonding compound conjugates forming i-motifs
US5925744A (en) Functional terpyridine-metal complexes, a process for the preparation thereof and oligonucleotide conjugates with terpyridine-metal complexes
HU219638B (hu) Terminálisan 3'-3'-, illetve 5'-5'-kötésekkel rendelkező oligoribonukleotid- és ribozim-analógok, valamint eljárás a vegyületek és az ezeket hatóanyagként tartalmazó gyógyszerkészítmények előállítására
Forget et al. 3′-Oligonucleotides conjugation via chemoselective oxime bond formation
CA2197785A1 (en) Oligonucleotide conjugates, compositions and methods for splitting ribonucleic acids
Taniguchi et al. The alkyl-connected 2-amino-6-vinylpurine (AVP) crosslinking agent for improved selectivity to the cytosine base in RNA
CN118146277A (zh) 一种含有1,2,3-三氮唑结构的GalNAc化合物及其与寡核苷酸缀合方法
Noe et al. Zwitterionic oligonucleotides: a study on binding properties of 2′-O-aminohexyl modifications
Adinolfi et al. Solid phase synthesis of oligonucleotides tethered to oligo-glucose phosphate tails
Winkler et al. 2′‐O‐Lysylaminohexyl Oligonucleotides: Modifications for Antisense and siRNA
Winkler et al. A novel concept for ligand attachment to oligonucleotides via a 2′‐succinyl linker
Asseline et al. Synthesis and binding properties of perylene-oligo-2′-deoxyribonucleotide conjugates
Pongracz et al. α-Oligodeoxyribonucleotide N3′→ P5′ phosphoramidates: synthesis and duplex formation
Lietard et al. Synthesis, binding and cellular uptake properties of oligodeoxynucleotides containing cationic bicyclo-thymidine residues
WO2008067825A1 (en) Hoogsteen-type triplex formation of pyrene labelled probes for nucleic acid detection in fluorescence assay
US5650399A (en) Reactive anthraquinone derivatives and conjugates thereof
Gupta et al. Synthesis and hybridization studies of α-configured arabino nucleic acids
JP6491233B2 (ja) ハイブリダイゼーション安定化用核酸複合体、核酸ハイブリダイゼーションの安定化方法、アンチセンス核酸医薬品及びｍｉｃｒｏＲＮＡ抑制剤
JP2005027569A (ja) 新規ｄｎａコンジュゲート及びそれを有効成分とするアンチセンス剤

Legal Events

Date Code Title Description
FZDE Dead